The Board proposes a rule amendment intended to update and clarify the application for licensure.

 

DEPARTMENT OF HEALTH

Board of Podiatric Medicine

RULE NO.:RULE TITLE:

64B18-11.001Application for Licensure

PURPOSE AND EFFECT: The Board proposes a rule amendment intended to update and clarify the application for licensure.

SUMMARY: The proposed rule updates the application for licensure.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board concluded that this rule change will not have any impact on licensees and their businesses or the businesses that employ them. The rule will not increase any fees, business costs, personnel costs, will not decrease profit opportunities, and will not require any specialized knowledge to comply. This change will not increase any direct or indirect regulatory costs. Hence, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.013, 461.005 FS.

LAW IMPLEMENTED: 456.013, 456.017(1)(c), 456.039, 456.048, 456.0635, 456.0135, 461.006, 465.0276, 465.039 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Ashleigh Irving, Executive Director, Board of Podiatric Medicine, 4052 Bald Cypress Way, Bin # C08, Tallahassee, Florida 32399-3258.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B18-11.001 Application for Licensure by Examination and Endorsement.

(1) Any person desiring to be licensed as a podiatric physician shall apply to the Board of Podiatric Medicine. The application shall be made on the Podiatric Physician Application for Licensure and Examination Form DH-MQA 1138 (revised 6/2022), hereby adopted and incorporated by reference, that can be obtained from http://www.flrules.org/Gateway/reference.asp?No=Ref-14886, and the web at https://floridaspodiatricmedicine.gov/ http://www.doh.state.fl.us/mqa/podiatry/index.html.

(2) An applicant for licensure by endorsement pursuant to section 456.0145(2), F.S., shall submit as part of his or her application DH-MQA-5101 (eff. 7/2024), Mobile Opportunity by Interstate Licensure Endorsement, which is incorporated herein by reference and which may be obtained from http://www.flrules.org/Gateway/reference.asp?No=Ref-________,the Board office, or at the Board’s website https://floridaspodiatricmedicine.gov/. Applicants for licensure shall meet and comply with all requirements in Section 456.0145(2), F.S.

(2) renumbered (3) No Change.

Rulemaking Authority 456.0145(5), 456.025, 456.013, 461.005, 490.004(4) FS. Law Implemented 456.013, 456.0145, 456.017(1)(c), 456.039, 456.048, 456.0635, 456.0135, 461.006, 465.0276, 465.039 FS. History–New 1-29-80, Amended 12-9-82, Formerly 21T-11.01, Amended 10-14-86, 1-26-88, 6-20-88, 7-3-89, 6-24-92, Formerly 21T-11.001, Amended 7-6-94, Formerly 61F12-11.001, Amended 1-1-96, 7-15-96, Formerly 59Z-11.001, Amended 9-3-98, 2-8-00, 4-22-08, 6-17-09, 2-11-10, 7-23-12, 11-21-12, 3-26-13, 11-15-16, 1-7-21, 6-17-21, 11-23-22,_____________.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Podiatric Medicine

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Podiatric Medicine

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: July 26, 2024

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: September 26, 2024